arrow
M

Maria A. Caligo

University Hospital of Pisa
H指数:51
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case report: A Newly Identified G-protein Subunit α-11 Loss-of-Function Variant Causing Familial Hypocalciuric Hypercalcemia Type 2 in an Italian Kindred

病例报告:在一个意大利家系中发现一种新型G蛋白亚基α-11失活功能变异导致2型家族性低钙尿性高钙血症

2026-09-100
OA
EP226 - ECE_1550 - Integrated clinical, genetic and histopathological analysis with long-term follow-up of nine Italian families harboring germline variants in the CDC73 gene

EP226 - ECE_1550 - 对携带CDC73基因胚系变异的九个意大利家庭进行整合临床、遗传和病理组织学分析及长期随访研究

2026-08-100
OAAI
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Role of MEN1 mutations on postoperative outcomes of patients with multiple endocrine neoplasia type 1-related primary hyperparathyroidism: a single center experience

MEN1基因突变对多发性内分泌腺瘤病1型相关原发性甲状旁腺功能亢进患者术后预后的影响:一项单中心经验

2025-11-120
PRE
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

卵巢癌病理特征是BRCA1和BRCA2变异致病性的预测因子

2023-04-198
OA
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

拷贝数变异可作为BRCA1/BRCA2致病变异携带者乳腺癌风险的调节剂

2022-10-067
OAAI
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

携带BRCA1和BRCA2致病错义变异体的女性与携带蛋白截断变异体的女性相比,患乳腺癌和卵巢癌的风险

2022-01-0117
OAAI
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

基于313变异的多基因风险评分对具有杂合BRCA1或BRCA2致病变异的欧洲血统女性对侧乳腺癌风险预测的预测能力

2021-09-0120
OAAI
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

使用多基因风险评分的男性BRCA1和BRCA2致病性变异携带者的乳腺癌和前列腺癌风险

2021-07-2829
OAAI